JPH06229970A - Humor constituent measuring device - Google Patents

Humor constituent measuring device

Info

Publication number
JPH06229970A
JPH06229970A JP5016229A JP1622993A JPH06229970A JP H06229970 A JPH06229970 A JP H06229970A JP 5016229 A JP5016229 A JP 5016229A JP 1622993 A JP1622993 A JP 1622993A JP H06229970 A JPH06229970 A JP H06229970A
Authority
JP
Japan
Prior art keywords
body fluid
measuring device
biosensor
antibacterial agent
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5016229A
Other languages
Japanese (ja)
Other versions
JP3149597B2 (en
Inventor
Toshiichi Tomioka
冨岡  敏一
Katsumi Tomita
冨田  勝己
Hiroaki Oka
弘章 岡
Kenji Hoshino
賢二 星野
Atsushi Nishino
西野  敦
Shiro Nankai
史朗 南海
Toshihiko Yoshioka
俊彦 吉岡
Kinichi Adachi
欣一 足立
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Priority to JP01622993A priority Critical patent/JP3149597B2/en
Publication of JPH06229970A publication Critical patent/JPH06229970A/en
Application granted granted Critical
Publication of JP3149597B2 publication Critical patent/JP3149597B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Sampling And Sample Adjustment (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

PURPOSE:To prevent an inspector from being infected by human immunity partial syndrome virus, hepatitis virus, etc., by allowing a member constituting a measuring device to carry an antibacterial agent or antivirus agent. CONSTITUTION:Silver paste is printed on an insulation substrate 21 by screen printing to form leads 22 and 23. Then, conductive carbon paste is printed, heated, and then dried, thus forming a measuring electrode 24 and a counter electrode 25. Further, insulation paste is printed and heated, thus forming an insulation layer 26. Then, a spacer 28 and a cover 29 are adhered and formed in one piece. The spacer 28 is provided with an introduction port 30 of a sample liquid and a space part 31 is formed at a center part. Also, a hole 32 of a cover 29 becomes the delivery port of air. A paint where antibacterial and antivirus silver silica gel antibacterial agent particles are kneaded applied to the surface excluding the electrode lead parts 22 and 23 of a biosensor thus produced, thus preventing propagation of contamination due to sampling of humor and preventing the danger of infection in inspection work.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】臨床検査において、種々の生体試
料中の特定成分を、迅速に精度よくかつ簡易に測定する
体液成分測定装置の改良に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an improvement of a body fluid component measuring device for rapidly, accurately and simply measuring a specific component in various biological samples in clinical tests.

【0002】[0002]

【従来の技術】近年、酵素の有する特異的触媒作用を利
用した種々のバイオセンサが開発され、特に臨床分野へ
の応用が試みられている、検査項目及び検体数が増加し
ている現在、迅速に精度よく測定できるバイオセンサが
望まれている。
2. Description of the Related Art In recent years, various biosensors utilizing the specific catalytic action of enzymes have been developed, and their application to the clinical field has been attempted. There is a demand for a biosensor that can accurately measure.

【0003】グルコースセンサを例にとると、糖尿病の
増加が著しい今日、血液中の血糖値を測定し管理するに
は、従来のように血液を遠心分離して血漿を測定するの
では非常に時間を要するため、全血で測定できるセンサ
が要求されている。簡易型としては、尿検査の時に使用
されている検査紙と同様に、スティック状の支持体に糖
(グルコース)にのみ反応する酵素と、酵素反応時また
は酵素反応の生成物により変化する色素とを含有する担
体を設置したものがある。この担体上に血液を滴下し、
一定時間後の色素の変化を目視または光学的に測定する
方式であるが、血液中の着色物による妨害が大きく精度
は低い。
Taking a glucose sensor as an example, in the present day when the increase of diabetes is remarkable, it is very time-consuming to measure and control blood glucose level in blood by centrifuging blood and measuring plasma. Therefore, a sensor that can measure whole blood is required. As a simple type, similar to the test paper used at the time of urinalysis, an enzyme that reacts only with sugar (glucose) on a stick-shaped support and a dye that changes during the enzymatic reaction or by the product of the enzymatic reaction. There is one in which a carrier containing is installed. Drop blood on this carrier,
This is a method of visually or optically measuring the change in the dye after a certain period of time, but the accuracy is low due to the large interference of colored substances in the blood.

【0004】そこで、図1のような多層式の分析担体が
提案されている(実開昭54−178495号公報)。
これは透明な支持体1の上に試薬層2、展開層3、防水
層4、濾過層5が順に積層された構造となっている。血
液サンプルを上部から滴下すると、まず濾過層5により
血液中の赤血球、血小板などの固形成分が除去され、防
水層4にある小孔6から展開層3へ均一に浸透し、試薬
層2において反応が進行する。反応終了後、透明な支持
体1を通して矢印の方向から光を照射し、比色分析によ
り基質濃度を測定する方式である。従来の簡易なスティ
ック状の担体と比較すると複雑な構造であるが、血球除
去などにより精度は向上した。しかし、血液の浸透およ
び反応に時間がかかるため、サンプルの乾燥を防ぐ防水
層4を必要とし、また、反応を速めるために高温でのイ
ンキュベートを要するなど、装置および担体が複雑化す
るという問題がある。
Therefore, a multi-layer type analytical carrier as shown in FIG. 1 has been proposed (Japanese Utility Model Publication No. 54-178495).
This has a structure in which a reagent layer 2, a spreading layer 3, a waterproof layer 4, and a filtration layer 5 are sequentially laminated on a transparent support 1. When a blood sample is dropped from the top, first, solid components such as red blood cells and platelets in the blood are removed by the filtration layer 5, and the solid components such as red blood cells and platelets permeate uniformly into the spreading layer 3 through the small holes 6 in the waterproof layer 4 and react in the reagent layer 2. Progresses. After completion of the reaction, light is irradiated from the direction of the arrow through the transparent support 1 and the substrate concentration is measured by colorimetric analysis. The structure is more complicated than the conventional simple stick-shaped carrier, but the accuracy is improved by removing blood cells. However, since it takes a long time for blood to penetrate and react, a waterproof layer 4 for preventing the sample from drying is required, and incubation at high temperature is required to accelerate the reaction, which complicates the device and the carrier. is there.

【0005】一方、血液などの生体試料中の特定成分に
ついて、試料液の希釈や撹拌などの操作を行なうことな
く高精度に定量する方式としては、図2に示すようなバ
イオセンサが提案されている(例えば、特開昭59−1
66852号公報)。このバイオセンサは、絶縁基板9
にリード7、8を各々有する白金などからなる測定極1
0および対極11を埋設し、これらの電極系の露出部分
を酸化還元酵素および電子受容体を担持した多孔体12
で覆ったものである。試料液を多孔体上へ滴下すると、
試料液中に酸化還元酵素と電子受容体が溶解し、試料液
中の基質との間で酵素反応が進行し、電子受容体が還元
される。反応終了後、この還元された電子受容体を電気
化学的に酸化し、このとき得られる酸化電流値から試料
中の基質濃度を求める。
On the other hand, a biosensor as shown in FIG. 2 has been proposed as a method for quantifying a specific component in a biological sample such as blood with high accuracy without performing operations such as dilution and stirring of the sample solution. (For example, JP-A-59-1
66852). This biosensor has an insulating substrate 9
Measuring electrode 1 made of platinum, etc., each having leads 7 and 8
0 and the counter electrode 11 are embedded, and the exposed parts of these electrode systems carry a redox enzyme and an electron acceptor to form a porous body 12.
It is covered with. When the sample solution is dropped on the porous body,
The oxidoreductase and the electron acceptor are dissolved in the sample solution, the enzymatic reaction proceeds with the substrate in the sample solution, and the electron acceptor is reduced. After the reaction is completed, the reduced electron acceptor is electrochemically oxidized, and the concentration of the substrate in the sample is determined from the oxidation current value obtained at this time.

【0006】しかし、このような構成では、多孔体につ
いては測定毎に取り替えることにより簡単に測定に供す
ることができるが、電極については洗浄等の操作が必要
である。一方、電極系をも含めて測定毎の使い捨てが可
能となれば、測定操作上、極めて簡易になるものの、白
金等の電極材料や構成等の面から、非常に高価なものに
ならざるを得ない。また白金電極の構成方法として、ス
パッタ法や蒸着法を用いることもできるが、製造上高価
なものとなる。
However, in such a structure, the porous body can be easily subjected to the measurement by exchanging it for each measurement, but the electrode requires an operation such as cleaning. On the other hand, if it is possible to dispose of each measurement including the electrode system, it will be extremely simple in terms of measurement operation, but it will have to be very expensive in terms of the electrode material and configuration such as platinum. Absent. Moreover, although a sputtering method or a vapor deposition method can be used as a method of forming the platinum electrode, it is expensive in manufacturing.

【0007】また、電極系をも含めて使い捨てにし得る
方式としては、特開昭61−294351号公報に記載
のバイオセンサを提案した。このバイオセンサは、図3
に示すように絶縁性の基板13の上にスクリーン印刷等
の方法でカーボンなどからなる電極系14(14’)、
15(15’)、16(16’)を形成し、絶縁層17
を設けた後、電極系の上を酸化還元酵素と電子受容体を
担持した多孔体19で覆い保持枠18とカバー20で全
体を一体化したものである。試料液を多孔体上へ滴下す
ると、多孔体に担持されている酸化還元酵素と電子受容
体が試料液に溶解し、試料液中の基質との間で酵素反応
が進行し電子受容体が還元される。反応終了後、この還
元された電子受容体を電気化学的に酸化し、このとき得
られる酸化電流値から試料液中の基質濃度を求める。
Further, as a method of making it disposable including the electrode system, a biosensor disclosed in Japanese Patent Application Laid-Open No. 61-294351 has been proposed. This biosensor is shown in FIG.
An electrode system 14 (14 ') made of carbon or the like on the insulating substrate 13 by a method such as screen printing as shown in FIG.
15 (15 ′) and 16 (16 ′) are formed, and the insulating layer 17 is formed.
After the above, the electrode system is covered with a porous body 19 carrying an oxidoreductase and an electron acceptor, and the holding frame 18 and a cover 20 are integrated as a whole. When the sample solution is dropped on the porous body, the redox enzyme and the electron acceptor supported on the porous body are dissolved in the sample solution, and the enzyme reaction proceeds with the substrate in the sample solution to reduce the electron acceptor. To be done. After the reaction is completed, the reduced electron acceptor is electrochemically oxidized, and the concentration of the substrate in the sample solution is determined from the oxidation current value obtained at this time.

【0008】[0008]

【発明が解決しようとする課題】近年、ヒト免疫不全症
候群ウイルス(HIV)、肝炎ウイルスなどが問題視さ
れる中、体液を扱う検査では、検査者の感染防止、さら
に検体の廃棄作業、廃棄までの間の取り扱いなど、検査
環境の改善が求められている。
In recent years, when human immunodeficiency syndrome virus (HIV), hepatitis virus, etc. have been regarded as problems, in the treatment of body fluids, the inspection of the inspector, the work of discarding the specimen, and the disposal of the specimen are also performed. It is required to improve the inspection environment such as handling during the period.

【0009】一方、体液成分測定装置を用いて種々の生
体試料中の特定成分を、迅速に精度よくかつ簡易に測定
できるため、個人的にも使用される場合が増大しつつあ
る。
On the other hand, since specific components in various biological samples can be measured quickly, accurately and simply by using a body fluid component measuring device, it is increasingly used for personal use.

【0010】もし被検者が体液を媒介とする伝染性のウ
イルス感染者であった場合その検体の適切な処理方法が
不可欠となる。
If the subject is a body fluid-borne infectious virus-infected subject, an appropriate method for treating the sample is essential.

【0011】[0011]

【課題を解決するための手段】本発明は、少なくとも体
液と酵素反応を利用する体液成分測定装置において、前
記測定装置を構成する部材の少なくとも一部に抗菌剤ま
たは抗ウイルス性剤を担持させたことをを特徴とする体
液成分測定装置である。また、本発明は測定器を有する
体液成分測定装置であって、該装置の本体部である前記
測定器は筺体の一部にバイオセンサの装着部を有し、前
記測定器の一部に抗菌剤または抗ウイルス性剤を担持さ
せたことを特徴とする体液成分測定装置である。さら
に、本発明は、体液採取器具を有し、前記体液採取器具
は筺体中に交換可能な刺針部を有してなり、前記筺体ま
たは刺針部などの体液採取器具の少なくとも一部に抗菌
剤または抗ウイルス性剤を担持させたことを特徴とす
る。また、本発明はバイオセンサ部は包装部材で梱包さ
れており、前記包装部材のの少なくとも一部に抗菌剤ま
たは抗ウイルス性剤を担持させたことを特徴とする。さ
らに本発明は、抗菌または抗ウイルス性材料として銀、
銀イオン、銀錯塩を用いることを特徴とする。
The present invention provides a body fluid component measuring apparatus utilizing at least a body fluid and an enzymatic reaction, wherein an antibacterial agent or an antiviral agent is carried on at least a part of members constituting the measuring apparatus. It is a body fluid component measuring device characterized by the above. Further, the present invention is a body fluid component measuring device having a measuring device, wherein the measuring device, which is the main body of the device, has a biosensor mounting part in a part of the housing, and an antibacterial part in the measuring device. A body fluid component measuring device, characterized in that it carries an agent or an antiviral agent. Furthermore, the present invention has a body fluid collecting device, wherein the body fluid collecting device has a replaceable needle part in the housing, and an antibacterial agent or an antibacterial agent is provided on at least a part of the body fluid collecting device such as the housing or the needle part. It is characterized by carrying an antiviral agent. Further, the present invention is characterized in that the biosensor part is packed in a packaging member, and an antibacterial agent or an antiviral agent is carried on at least a part of the packaging member. The present invention further provides silver as an antibacterial or antiviral material,
It is characterized by using silver ions and silver complex salts.

【0012】[0012]

【作用】体液成分測定装置を取り扱う際に手に触れ易い
部分、即ちバイオセンサのみならず体液成分測定装置の
本体である測定器や体液採取器具、さらにはバイオセン
サの包装部材などの表面に抗菌剤あるいは抗ウイルス性
剤を担持することにより測定器などの器具に付着した体
液中のウイルスを殺すことができ、汚染の伝搬を防ぐこ
とができる。さらに体液採取時などに直接手指に付着し
た体液が体液成分測定装置に付着介在する二次汚染も、
測定器などに担持させた抗菌あるいは抗ウイルス性剤に
より防止できる。
[Function] An antibacterial agent is applied to a portion which is easily touched when handling the body fluid component measuring device, that is, the surface of not only the biosensor but also the measuring device and the body fluid collecting instrument which is the body of the body fluid component measuring device, and the packaging member of the biosensor. By carrying the agent or the antiviral agent, the virus in the body fluid attached to the instrument such as the measuring instrument can be killed, and the propagation of the contamination can be prevented. In addition, the secondary contamination caused by the body fluid that directly adheres to the finger when collecting body fluid adheres to the body fluid component measuring device,
It can be prevented by an antibacterial or antiviral agent carried on a measuring instrument or the like.

【0013】[0013]

【実施例】【Example】

(実施例1)以下の実施例の説明用図面において、共通
する要素には同一番号を付し、一部説明を省略する。
(Embodiment 1) In the drawings for explaining the following embodiments, common elements are designated by the same reference numerals, and the description thereof will be partially omitted.

【0014】バイオセンサの一例として、グルコースセ
ンサについて説明する。図4は本発明のバイオセンサの
一実施例として作製したグルコースセンサの分解斜視図
であり、図5はその外観図、また図6は、図5に示すバ
イオセンサを長手方向に中央部で切断した場合の断面図
である。なお、図4には、図6に示す反応層274は示
されていない。
A glucose sensor will be described as an example of a biosensor. FIG. 4 is an exploded perspective view of a glucose sensor manufactured as an example of the biosensor of the present invention, FIG. 5 is an external view thereof, and FIG. 6 is a sectional view of the biosensor shown in FIG. It is sectional drawing at the time of doing. The reaction layer 274 shown in FIG. 6 is not shown in FIG.

【0015】以下に、センサの作製方法について説明す
る。ポリエチレンテレフタレートからなる絶縁性の基板
21に、スクリーン印刷により銀ペ−ストを印刷しリ−
ド22,23(23′)を形成する。次に、樹脂バイン
ダーを含む導電性カーボンペーストを印刷し、加熱乾燥
することにより、測定極24、対極25(25′)から
なる電極系を形成する。さらに、電極系を部分的に覆
い、電極の露出部分の面積を一定とし、かつリ−ドの不
要部を覆うように絶縁性ペーストを印刷し、加熱処理を
して絶縁層26を形成する。
The method of manufacturing the sensor will be described below. A silver paste is printed on the insulating substrate 21 made of polyethylene terephthalate by screen printing and then reprinted.
To form the cords 22 and 23 (23 '). Next, a conductive carbon paste containing a resin binder is printed and heated and dried to form an electrode system including the measurement electrode 24 and the counter electrode 25 (25 '). Further, an insulating paste is printed so as to partially cover the electrode system, keep the area of the exposed portion of the electrode constant, and cover unnecessary portions of the lead, and heat treatment is performed to form the insulating layer 26.

【0016】次に、電極系24、25(25′)の露出
部分を研磨後、空気中で100℃にて4時間熱処理を施
した。このようにして電極部分を構成した後、親水性高
分子として、カルボキシメチルセルロ−ス(以下CMC
と略す)の0.5wt%水溶液を電極上へ展開、乾燥しC
MC層を形成する。そしてこのCMC層を覆うように、
酵素としてグルコースオキシダーゼ(GOD)をリン酸
緩衝液に溶解したものを展開し、乾燥させ、CMC−G
OD層からなる反応層27を形成した。この場合、CM
CとGODは部分的に混合された状態で厚さ数ミクロン
の薄膜状となっている。
Next, the exposed portions of the electrode systems 24, 25 (25 ') were polished and then heat-treated in air at 100 ° C. for 4 hours. After forming the electrode portion in this way, carboxymethyl cellulose (hereinafter referred to as CMC) is used as a hydrophilic polymer.
Abbreviated to 0.5 wt% aqueous solution is spread on the electrode, dried and
Form the MC layer. And to cover this CMC layer,
Glucose oxidase (GOD) as an enzyme dissolved in a phosphate buffer was developed, dried, and then CMC-G.
A reaction layer 27 composed of an OD layer was formed. In this case, CM
C and GOD are in a partially mixed state in the form of a thin film having a thickness of several microns.

【0017】次に、この基板21と樹脂板からなるスペ
−サ28とカバ−29の3つの部材について、図4に示
す様に、各部材間が破線で示す位置関係になるように接
着し、図5の外観図に示すように一体化した。ここで、
スペ−サは約300μmの厚みを有し、その中央部を幅
2mmで長さ方向にU型に切りとった形状をしており、切
りとられた部分の端部は一体化したときに試料液の導入
口30となり、中央部は空間部31を形成する。また、
カバ−29は直径2mmの穴を有しており、一体化したと
きに空間部内の空気の排出口32となる。
Next, as shown in FIG. 4, the three members of the substrate 21, the spacer 28 made of a resin plate and the cover 29 are bonded so that the respective members have a positional relationship shown by a broken line. , As shown in the external view of FIG. here,
The spacer has a thickness of about 300 μm, and has a shape in which the central portion is cut into a U shape with a width of 2 mm in the longitudinal direction, and the end portion of the cut portion is the sample solution when integrated. And the central portion forms a space portion 31. Also,
The cover 29 has a hole with a diameter of 2 mm, and becomes a discharge port 32 for air in the space when integrated.

【0018】このように作製されたバイオセンサの電極
リード部を除く表面に抗菌、抗ウイルス性の銀シリカゲ
ル系抗菌剤粒子を混練した塗料を塗布する。
A coating prepared by kneading antibacterial and antiviral silver silica gel type antibacterial agent particles is applied to the surface of the biosensor thus manufactured excluding the electrode lead portions.

【0019】上記塗料は、ウレタン系塗料に塗料樹脂成
分の5wt%の銀シリカゲル系の抗菌、抗ウイルス性の
粒子を分散混練させたもので、溶剤により適宜希釈した
ものである。
The above-mentioned paint is a urethane paint in which 5 wt% silver silica gel antibacterial and antiviral particles of a paint resin component are dispersed and kneaded, and appropriately diluted with a solvent.

【0020】次に上記銀シリカゲル系抗菌、抗ウイルス
性剤粒子についてその製法と共に説明する。
Next, the above-mentioned silver-silica gel type antibacterial and antiviral agent particles will be described together with their manufacturing method.

【0021】酢酸銀などの水溶性銀塩100重量部を塩
素を含まない水に加えて溶解させ、亜硫酸ナトリウムお
よび亜硫酸水素ナトリウムの混合物450重量部、およ
びチオ硫酸ナトリウムの水溶性塩300重量部を順次、
充分撹拌しながら混合し溶解させ、銀錯塩水溶液を得
た。なお、チオ硫酸ナトリウムの重量は、その水和物N
223・5H2Oの重量として示される。
100 parts by weight of a water-soluble silver salt such as silver acetate was added to and dissolved in water containing no chlorine, and 450 parts by weight of a mixture of sodium sulfite and sodium bisulfite, and 300 parts by weight of a water-soluble salt of sodium thiosulfate were added. Sequentially
The mixture was thoroughly stirred and dissolved to obtain a silver complex salt aqueous solution. The weight of sodium thiosulfate is the hydrate N
It is shown as the weight of a 2 S 2 O 3 · 5H 2 O.

【0022】本実施例の銀シリカゲル系抗菌、抗ウイル
ス性剤粒子に用いる担体は、「JIS Z 0701包
装用シリカゲル乾燥剤」に記載のB型のシリカゲル粉末
である。このB型シリカゲル粉末は、低湿度では吸湿率
が低く、高湿度では吸湿率が高く、かつ高湿度における
総吸湿量の高いシリカゲル粉末であり、その平均粒径は
8μm程度である。
The carrier used for the silver silica gel antibacterial and antiviral agent particles in this example is B-type silica gel powder described in "JIS Z 0701 Silica gel desiccant for packaging". This B-type silica gel powder is a silica gel powder having a low moisture absorption rate at low humidity, a high moisture absorption rate at high humidity, and a high total moisture absorption amount at high humidity, and its average particle size is about 8 μm.

【0023】上記シリカゲル粉末を180℃で2時間以
上乾燥させた。得られたシリカゲル100重量部に対
し、銀成分として2重量部になるように前記チオスルフ
ァト銀錯塩水溶液を混合した。次いで、速やかに溶媒お
よび担体中に吸収された水分を除去した。次いで、これ
を所定の粒径に粉砕して、銀錯塩を担持したシリカゲル
を得た。
The silica gel powder was dried at 180 ° C. for 2 hours or more. The thiosulfato silver complex salt aqueous solution was mixed with 100 parts by weight of the obtained silica gel so that the silver component was 2 parts by weight. Then, the water absorbed in the solvent and the carrier was promptly removed. Then, this was crushed to a predetermined particle size to obtain a silica gel carrying a silver complex salt.

【0024】コーティング材料としてテトラエトキシシ
ラン100重量部をエチルアルコール100重量部に希
釈混合させた溶液に、上記シリカゲル100重量部を分
散させた後、これに純水20重量部を加えてテトラエト
キシシランを加水分解させ、上記シリカゲルの表面の少
なくとも1部をコーティングした。次いでこれを乾燥さ
せて銀シリカゲル系抗菌、抗ウイルス性剤粒子を得た。
As a coating material, 100 parts by weight of silica gel was dispersed in a solution prepared by diluting 100 parts by weight of tetraethoxysilane with 100 parts by weight of ethyl alcohol, and then 20 parts by weight of pure water was added thereto to add tetraethoxysilane. Was hydrolyzed and at least part of the surface of the silica gel was coated. Then, this was dried to obtain silver silica gel antibacterial and antiviral agent particles.

【0025】(実施例2)内部に演算回路を、表面中央
に血糖値、GOT値、GPT値、尿酸値、コレステロー
ル値、乳酸値などを表示する表示部を有する5cmX1
0cmX1cm厚みの体液成分測定装置の本体である測
定器の筺体は、ABS樹脂で構成されている。また、こ
の測定器には前記体液成分を検知するバイオセンサの装
着部を有している。
(Embodiment 2) A 5 cm × 1 unit having an arithmetic circuit inside and a display unit for displaying a blood glucose level, a GOT value, a GPT value, a uric acid level, a cholesterol level, a lactic acid level, etc. in the center of the surface.
The casing of the measuring instrument, which is the main body of the body fluid component measuring device having a thickness of 0 cm × 1 cm, is made of ABS resin. Further, this measuring instrument has a biosensor mounting portion for detecting the body fluid component.

【0026】このABS樹脂を成型する原料樹脂に1.
5wt%の実施例1で述べた銀シリカゲル系抗菌、抗ウ
イルス性剤粒子を混練しカラードペレットを得る。この
カラードペレットで射出成型し、上記筺体が得られる。
The raw material resin for molding this ABS resin is 1.
5 wt% of the silver silica gel-based antibacterial and antiviral agent particles described in Example 1 are kneaded to obtain colored pellets. The colored pellets are injection-molded to obtain the above housing.

【0027】(実施例3)体液採取器具を有する体液成
分測定装置における一実施例について説明する。
(Embodiment 3) An embodiment of a body fluid component measuring device having a body fluid collecting device will be described.

【0028】体液採取器具は筺体中に交換可能な刺針部
を有するものであり、前記筺体や前記刺針部をはじめと
して、体液採取器具の少なくともいずれか一部分に抗菌
剤または抗ウイルス性剤を担持させることができる。
The body fluid collecting device has a replaceable needle part in the housing, and an antibacterial agent or an antiviral agent is carried on at least part of the body fluid collecting device including the housing and the needle part. be able to.

【0029】ポリプロピレン樹脂に対し2%の上記銀シ
リカゲル系抗菌剤粒子を混練しカラードペレットを得
る。このカラードペレットで体液採取器具に用いる刺針
を成形型に保持させて射出成型し、ホルダーつき刺針部
が得られる。実施例2同様、ABS原料樹脂に1.5w
t%の上記銀シリカゲル系抗菌剤粒子を混練したカラー
ドペレットで射出成型し、体液採取具筺体が得られる。
2% of the above silver-silica gel type antibacterial agent particles are kneaded with polypropylene resin to obtain colored pellets. The colored pellets are used to hold a puncture needle used in a body fluid collecting device in a molding die and injection-molded to obtain a puncture needle portion with a holder. As in Example 2, 1.5w for ABS raw material resin
A body fluid sampling tool housing is obtained by injection molding with colored pellets in which t% of the above-mentioned silver silica gel antibacterial agent particles are kneaded.

【0030】(実施例4)実施例1のバイオセンサは使
用直前まで滅菌された状態などを保持するため包装部材
に収納されている。この包装部材としてはは例えばアル
ミ箔に樹脂フィルムをラミネートしたものであり、包装
部材内部に上記銀シリカゲル系抗菌、抗ウイルス性剤粒
子をバイオセンサの導入口などに直接触れない様な形態
で配している。すなわち銀シリカゲル剤を、樹脂フィル
ム表面に塗布ししたり、混錬した樹脂フィルム最も内側
に積層するなどの方法により配している。さらには包装
部材内に収納されている乾燥剤などと同梱されている。
(Embodiment 4) The biosensor of Embodiment 1 is housed in a packaging member in order to maintain a sterilized state until just before use. The packaging member is, for example, an aluminum foil laminated with a resin film, and the silver silica gel antibacterial and antiviral agent particles are arranged inside the packaging member in a form that does not directly touch the inlet of the biosensor. is doing. That is, the silver silica gel agent is applied by coating the surface of the resin film or by laminating the kneaded resin film on the innermost side. Furthermore, it is packaged with a desiccant or the like contained in the packaging member.

【0031】上記実施例1〜4の抗菌、抗ウイルス処理
した部材について下記に示すような抗ウイルス試験を行
った。その結果を(表1)に示す。(表1)より、本実
施例の抗菌抗ウイルス性材料は実用的な抗ウイルス性能
を有することがわかる。
The following anti-virus tests were conducted on the members subjected to the anti-bacterial and anti-virus treatments of Examples 1 to 4 above. The results are shown in (Table 1). From Table 1, it can be seen that the antibacterial and antiviral material of this example has a practical antiviral performance.

【0032】抗ウイルス試験:ポリオウイルス、はしか
ウイルス、HIVを始め種々のウイルスを用い、各ウイ
ルスを検体と1:1の割合で混合し、1時間後アフリカ
ミドリザル腎臓由来vero細胞106cells/m
lに感染させ1週間の細胞の生死及び形態変化により評
価を行った。検体は銀シリカゲル系抗菌、抗ウイルス性
剤粒子1mgに対して1mlの培養液を加えて30分間抽
出して検体としたものを1、10、100 nM, 1、1
0、100 μMの各濃度で用いた。
Antivirus test: Various viruses including poliovirus, measles virus, HIV were used, and each virus was mixed with a sample at a ratio of 1: 1. After 1 hour, African green monkey kidney-derived vero cells 10 6 cells / m
The evaluation was carried out based on the life and death and morphological change of cells infected with 1 for 1 week. Samples were prepared by adding 1 ml of culture solution to 1 mg of silver-silica gel antibacterial and antiviral agent particles and extracting for 30 minutes to obtain 1, 10, 100 nM, 1, 1
Used at each concentration of 0,100 μM.

【0033】上記実施例においては抗菌抗ウイルス性材
料として銀シリカゲル系抗菌剤粒子を用いたが、チオス
ルファト銀錯塩及び銀、銀イオンの少なくとも1種の抗
菌抗ウイルス性材料を混合して用いることもできる。
Although silver silica gel type antibacterial agent particles are used as the antibacterial and antiviral material in the above examples, it is also possible to use a mixture of thiosulfato silver complex salt and at least one antibacterial and antiviral material of silver and silver ion. it can.

【0034】(比較例1)実施例2において、ABS樹
脂のみを成型して、実施例2と同様の形状の樹脂筺体を
得、この樹脂筺体について、実施例2と同様にして抗ウ
イルス試験を行った。その結果を(表1)に示す。
(Comparative Example 1) In Example 2, only the ABS resin was molded to obtain a resin casing having the same shape as in Example 2, and this resin casing was subjected to the antivirus test in the same manner as in Example 2. went. The results are shown in (Table 1).

【0035】[0035]

【表1】 [Table 1]

【0036】[0036]

【発明の効果】体液成分測定装置を取り扱う際に手に触
れ易い部分、即ちバイオセンサのみならず体液成分測定
装置の本体である測定器や体液採取器具などの表面に抗
菌、抗ウイルス性剤を配することにより、体液採取に伴
う汚染の伝搬を防ぐことができる。また体液採取者の体
液採取検査作業に対する感染の危険性を防ぐことができ
る。
EFFECTS OF THE INVENTION An antibacterial or antiviral agent is applied to the part which is easily touched when handling a body fluid component measuring device, that is, the surface of not only the biosensor but also the measuring device or the body fluid collecting device which is the body of the body fluid component measuring device. By arranging them, it is possible to prevent the propagation of contamination associated with the collection of body fluid. In addition, it is possible to prevent the risk of infection in the body fluid collection inspection work of the body fluid collector.

【0037】さらに、体液採取後の検体に対する抗ウイ
ルス性により使用済み検体による環境汚染が低減され、
滅菌設備の無い家庭でも容易に検査を実施することがで
きるという効果が期待できる。
Furthermore, the anti-virus property against the sample after collecting the body fluid reduces the environmental pollution due to the used sample,
It can be expected that the inspection can be easily performed even at home without sterilization equipment.

【図面の簡単な説明】[Brief description of drawings]

【図1】従来例の多層式の分析担体の説明図FIG. 1 is an explanatory view of a conventional multi-layer type analytical carrier.

【図2】従来例のバイオセンサの説明図FIG. 2 is an explanatory view of a conventional biosensor.

【図3】従来例のバイオセンサの説明図FIG. 3 is an explanatory diagram of a conventional biosensor.

【図4】本発明の一実施例のバイオセンサであるグルコ
ースセンサの分解斜視図
FIG. 4 is an exploded perspective view of a glucose sensor that is a biosensor according to an embodiment of the present invention.

【図5】同実施例のバイオセンサの外観図FIG. 5 is an external view of the biosensor of the same example.

【図6】同実施例のバイオセンサを長手方向に中央部で
切断した場合の断面図
FIG. 6 is a cross-sectional view of the biosensor of the same example taken along the longitudinal direction at the central portion.

【符号の説明】[Explanation of symbols]

1 支持体 2 試薬層 3 展開層 4 防水層 5 濾過層 6 小孔 7 リード 8 リード 9 絶縁基板 10 測定極 11 対極 12 多孔体 13 絶縁性の基板 14 電極系 15 電極系 16 電極系 17 絶縁層 18 保持枠 19 多孔体 20 カバー 21 絶縁性の基板 22 リード 23(23’) リード 24 測定極 25(25’) 対極 26 絶縁層 27 反応層 28 スペ−サ 29 カバ− 30 試料液の導入口 31 空間部 32 排出口 1 Support 2 Reagent Layer 3 Development Layer 4 Waterproof Layer 5 Filtration Layer 5 Small Hole 7 Lead 8 Lead 9 Insulating Substrate 10 Measuring Electrode 11 Counter Electrode 12 Porous Body 13 Insulating Substrate 14 Electrode System 15 Electrode System 16 Electrode System 17 Insulation Layer 18 Holding Frame 19 Porous Body 20 Cover 21 Insulating Substrate 22 Lead 23 (23 ') Lead 24 Measuring Electrode 25 (25') Counter Electrode 26 Insulating Layer 27 Reaction Layer 28 Spacer 29 Cover 30 Sample Liquid Inlet 31 Space 32 outlet

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 G01N 1/10 V 7519−2J 27/327 (72)発明者 星野 賢二 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 (72)発明者 西野 敦 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 (72)発明者 南海 史朗 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 (72)発明者 吉岡 俊彦 大阪府門真市大字門真1006番地 松下電器 産業株式会社内 (72)発明者 足立 欣一 大阪府門真市大字門真1006番地 松下電器 産業株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification number Internal reference number FI Technical indication location G01N 1/10 V 7519-2J 27/327 (72) Inventor Kenji Hoshino 1006 Kadoma, Kadoma, Osaka Prefecture Address Matsushita Electric Industrial Co., Ltd. (72) Inventor Atsushi Nishino 1006 Kadoma, Kadoma City, Osaka Prefecture Matsushita Electric Industrial Co., Ltd. (72) Inventor Shiro Nankai 1006 Kadoma, Kadoma City, Osaka Pref. 72) Inventor Toshihiko Yoshioka 1006 Kadoma, Kadoma City, Osaka Prefecture Matsushita Electric Industrial Co., Ltd. (72) Kinichi Adachi, 1006 Kadoma, Kadoma City, Osaka Prefecture Matsushita Electric Industrial Co., Ltd.

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】体液と酵素反応を利用する体液成分測定装
置において、前記測定装置を構成する部材の少なくとも
一部に抗菌剤または抗ウイルス性剤を担持させたことを
を特徴とする体液成分測定装置。
1. A body fluid component measuring apparatus utilizing an enzymatic reaction with a body fluid, characterized in that an antibacterial agent or an antiviral agent is carried on at least a part of members constituting the measuring apparatus. apparatus.
【請求項2】筺体の一部にバイオセンサの装着部を有
し、前記バイオセンサにおける反応層と体液による電気
化学変化を計測、演算し、種々の生体試料中の特定成分
量に変換表示する測定器において、前記測定器を構成す
る部材の少なくとも一部に抗菌剤または抗ウイルス性剤
を担持させたことを特徴とする請求項1記載の体液成分
測定装置。
2. A biosensor mounting portion is provided in a part of the housing, and electrochemical changes due to a reaction layer and body fluid in the biosensor are measured and calculated, and converted into specific component amounts in various biological samples and displayed. The body fluid component measuring device according to claim 1, wherein in the measuring device, an antibacterial agent or an antiviral agent is carried on at least a part of members constituting the measuring device.
【請求項3】バイオセンサは、電極系と反応層を有する
基板上に前記反応層を含む空間部を形成し、前記空間部
に被検液を導入する導入口と、前記空間部の気体を前記
被検液の流入によって排出する排出口を具備し、前記電
極系は少なくとも測定極と対極を備え、前記反応層には
少なくとも酵素を担持してなり、前記酵素と前記被検液
の反応に際しての物質濃度変化を前記電極系を介し測定
器本体に入力し、前記被検液中の基質濃度を測定するも
のであり、前記バイオセンサを構成する部材表面の少な
くとも一部に抗菌剤または抗ウイルス性剤を担持させた
ことを特徴とする請求項1記載の体液成分測定装置。
3. A biosensor, wherein a space portion including the reaction layer is formed on a substrate having an electrode system and a reaction layer, and an inlet for introducing a test liquid into the space portion and a gas in the space portion are provided. The test solution has an outlet for discharging the test solution, the electrode system has at least a measuring electrode and a counter electrode, and the reaction layer carries at least an enzyme, and the reaction of the enzyme with the test solution is carried out. The substance concentration change is input to the measuring device main body through the electrode system to measure the substrate concentration in the test liquid, and an antibacterial agent or antiviral agent is provided on at least a part of the surface of the member constituting the biosensor. The body fluid component measuring device according to claim 1, which carries a sexual agent.
【請求項4】体液採取器具を有する体液成分測定装置に
おいて、前記体液採取器具は筺体中に交換可能な刺針部
を有してなり、前記体液採取器具の少なくとも一部分に
抗菌剤または抗ウイルス性剤を担持させたことを特徴と
する請求項1記載の体液成分測定装置。
4. A body fluid component measuring apparatus having a body fluid collecting device, wherein the body fluid collecting device has a replaceable needle part in a housing, and an antibacterial agent or an antiviral agent is provided on at least a part of the body fluid collecting device. The body fluid component measuring device according to claim 1, wherein
【請求項5】バイオセンサ部は包装部材で梱包されてお
り、前記包装部材のの少なくとも一部に抗菌剤または抗
ウイルス性剤を有する請求項1記載の体液成分測定装
置。
5. The body fluid component measuring device according to claim 1, wherein the biosensor part is packed with a packaging member, and at least a part of the packaging member has an antibacterial agent or an antiviral agent.
【請求項6】抗菌剤または抗ウイルス性剤として銀、銀
イオン、銀錯塩のすくなくと一種を用いることを特徴と
する請求項1、2、3、4または5記載の体液成分測定
装置。
6. The body fluid component measuring device according to claim 1, wherein at least one of silver, silver ion, and silver complex salt is used as the antibacterial agent or antiviral agent.
【請求項7】抗菌剤または抗ウイルス性剤は、シリカゲ
ルにチオスルファト銀錯塩を担持した後、少なくともそ
の表面の一部をテトラアルコキシシランの加水分解で被
覆してなることを特徴とする請求項6記載の体液成分測
定装置。
7. The antibacterial agent or antiviral agent is characterized in that after silica thiosulfato silver complex salt is supported on silica gel, at least a part of the surface thereof is coated by hydrolysis of tetraalkoxysilane. The body fluid component measuring device described.
JP01622993A 1993-02-03 1993-02-03 Body fluid component measurement device Expired - Fee Related JP3149597B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP01622993A JP3149597B2 (en) 1993-02-03 1993-02-03 Body fluid component measurement device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP01622993A JP3149597B2 (en) 1993-02-03 1993-02-03 Body fluid component measurement device

Publications (2)

Publication Number Publication Date
JPH06229970A true JPH06229970A (en) 1994-08-19
JP3149597B2 JP3149597B2 (en) 2001-03-26

Family

ID=11910722

Family Applications (1)

Application Number Title Priority Date Filing Date
JP01622993A Expired - Fee Related JP3149597B2 (en) 1993-02-03 1993-02-03 Body fluid component measurement device

Country Status (1)

Country Link
JP (1) JP3149597B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086483A1 (en) * 2001-04-16 2002-10-31 Matsushita Electric Industrial Co., Ltd. Biosensor
WO2003010530A1 (en) * 2001-07-27 2003-02-06 Arkray, Inc. Analyzing instrument
DE10352575B3 (en) * 2003-11-11 2005-05-04 Leica Microsystems Nussloch Gmbh Cryostat with an inner container for receiving a microtome
JP2006314831A (en) * 2006-07-31 2006-11-24 Arkray Inc Lancet integrated body liquid measurement apparatus and mounted body used by mounting thereon
KR100896234B1 (en) * 2007-08-10 2009-05-08 주식회사 아이센스 Electrochemical biosensor and measuring instrument thereof
JP2009156816A (en) * 2007-12-27 2009-07-16 Horiba Ltd Chip for analyzing liquid to be inspected
WO2010021429A1 (en) * 2008-08-22 2010-02-25 I-Sens, Inc. Biosensor measuring apparatus and a method thereof
WO2011114705A1 (en) * 2010-03-19 2011-09-22 ミツミ電機株式会社 Biosensor kit
JP2013235013A (en) * 2013-07-24 2013-11-21 Mitsumi Electric Co Ltd Biosensor kit
JP2017025170A (en) * 2015-07-17 2017-02-02 大建工業株式会社 Antivirus coating composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11490846B2 (en) 2016-06-30 2022-11-08 Tatsuta Electric Wire & Cable Co., Ltd. Bioelectrode and method for producing bioelectrode

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8475638B2 (en) 2001-04-16 2013-07-02 Panasonic Corporation Biosensor
CN100401050C (en) * 2001-04-16 2008-07-09 松下电器产业株式会社 Biosensor
WO2002086483A1 (en) * 2001-04-16 2002-10-31 Matsushita Electric Industrial Co., Ltd. Biosensor
WO2003010530A1 (en) * 2001-07-27 2003-02-06 Arkray, Inc. Analyzing instrument
CN1300578C (en) * 2001-07-27 2007-02-14 爱科来株式会社 Analyzing instrument
US7824616B2 (en) 2001-07-27 2010-11-02 Arkray, Inc. Analyzing instrument
US8425841B2 (en) 2001-07-27 2013-04-23 Arkray, Inc. Analyzing instrument
DE10352575B3 (en) * 2003-11-11 2005-05-04 Leica Microsystems Nussloch Gmbh Cryostat with an inner container for receiving a microtome
JP2006314831A (en) * 2006-07-31 2006-11-24 Arkray Inc Lancet integrated body liquid measurement apparatus and mounted body used by mounting thereon
JP4635140B2 (en) * 2006-07-31 2011-02-16 アークレイ株式会社 Lancet-integrated body fluid measuring device and attached body to be used by attaching to this body fluid measuring device
KR100896234B1 (en) * 2007-08-10 2009-05-08 주식회사 아이센스 Electrochemical biosensor and measuring instrument thereof
JP2009156816A (en) * 2007-12-27 2009-07-16 Horiba Ltd Chip for analyzing liquid to be inspected
US8226004B2 (en) 2008-08-22 2012-07-24 I-Sens, Inc. Biosensor measuring apparatus and a method thereof
WO2010021429A1 (en) * 2008-08-22 2010-02-25 I-Sens, Inc. Biosensor measuring apparatus and a method thereof
JP2011196850A (en) * 2010-03-19 2011-10-06 Mitsumi Electric Co Ltd Biosensor chip, biosensor kit, and detection object material detection system
WO2011114705A1 (en) * 2010-03-19 2011-09-22 ミツミ電機株式会社 Biosensor kit
US8710554B2 (en) 2010-03-19 2014-04-29 Mitsumi Electric, Co., Ltd. Biosensor kit
US8716762B2 (en) 2010-03-19 2014-05-06 Mitsumi Electric Co., Ltd. Biosensor kit
JP2013235013A (en) * 2013-07-24 2013-11-21 Mitsumi Electric Co Ltd Biosensor kit
JP2017025170A (en) * 2015-07-17 2017-02-02 大建工業株式会社 Antivirus coating composition

Also Published As

Publication number Publication date
JP3149597B2 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
EP0359831B1 (en) Biosensor and process for its production
CN2372689Y (en) Current biological sensor
JP3574113B2 (en) Improved electrochemical biosensor test strip with notch
CN1432814A (en) Reference composite and method of using it in condensation experiment
EP2228645B1 (en) Method, device and apparatus for measuring the concentration of creatinine, and method, device and apparatus for measuring the amount of salt using the same
WO1984003562A1 (en) Biosensor
CN1441903A (en) Hemoglobin sensor
JPH0777511A (en) Biosensor for gas measurement and preparation thereof
JP3149597B2 (en) Body fluid component measurement device
JP6397822B2 (en) Device and method of using the device for detection of aminoacidopathy
CA2807519C (en) Test sensor reagent having cellulose polymers
WO1994028405A1 (en) Electrochemical metal analysis
de Araujo et al. Low-Cost Biosensor Technologies for Rapid Detection of COVID-19 and Future Pandemics
JP3487410B2 (en) Biosensor
JP4467711B2 (en) Enzyme sensor and enzyme sensor device using the same
JP2017009550A (en) Biosensor
JP2950592B2 (en) Multilayer analytical tool for fructosamine measurement
CN109900689A (en) Interference rejection membrane and liver function joint test item
US20180321202A1 (en) Methods and devices for detecting methanol poisoning using formate oxidase
Davis Advances in biomedical sensor technology: a review of the 1985 patent literature
JPH026737A (en) Sugar content measuring instrument
JPS63317096A (en) Biosensor
EP3404418A2 (en) A diagnostic strip for determining the amount of sarcosine, creatinine and hydrogen peroxide in a biological or environmental sample
Russell et al. The commercialisation of sensor technology in clinical chemistry: an outline of the potential difficulties
JP2002221508A (en) Biosensor

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees